Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 3
1955 2
1968 1
1976 1
1977 2
1991 1
1992 1
1995 1
1998 1
1999 1
2000 1
2002 2
2003 3
2004 2
2005 3
2006 5
2007 2
2008 3
2009 3
2010 2
2011 2
2012 2
2013 3
2014 2
2015 4
2016 11
2017 5
2018 11
2019 13
2020 14
2021 14
2022 12
2023 10
2024 14
2025 13
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Results by year

Filters applied: . Clear all
Page 1
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
Yau T, Kaseb A, Cheng AL, Qin S, Zhu AX, Chan SL, Melkadze T, Sukeepaisarnjaroen W, Breder V, Verset G, Gane E, Borbath I, Rangel JDG, Ryoo BY, Makharadze T, Merle P, Benzaghou F, Milwee S, Wang Z, Curran D, Kelley RK, Rimassa L. Yau T, et al. Among authors: rangel jdg. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):310-322. doi: 10.1016/S2468-1253(23)00454-5. Epub 2024 Feb 13. Lancet Gastroenterol Hepatol. 2024. PMID: 38364832 Clinical Trial.
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.
Kelley RK, Rimassa L, Cheng AL, Kaseb A, Qin S, Zhu AX, Chan SL, Melkadze T, Sukeepaisarnjaroen W, Breder V, Verset G, Gane E, Borbath I, Rangel JDG, Ryoo BY, Makharadze T, Merle P, Benzaghou F, Banerjee K, Hazra S, Fawcett J, Yau T. Kelley RK, et al. Among authors: rangel jdg. Lancet Oncol. 2022 Aug;23(8):995-1008. doi: 10.1016/S1470-2045(22)00326-6. Epub 2022 Jul 4. Lancet Oncol. 2022. PMID: 35798016 Free article. Clinical Trial.
Innovations in Varroa mite management.
Whitehouse M, Yousuf F, Sainsbury J, Rangel J, Goodwin M. Whitehouse M, et al. Among authors: rangel j. Curr Opin Insect Sci. 2025 Apr;68:101343. doi: 10.1016/j.cois.2025.101343. Epub 2025 Feb 3. Curr Opin Insect Sci. 2025. PMID: 39909097 Free article. Review.
Engaging cultural humility diffractively.
Crath R, Rangel JC. Crath R, et al. Among authors: rangel jc. J Eval Clin Pract. 2021 Jun;27(3):554-561. doi: 10.1111/jep.13409. Epub 2020 Jun 11. J Eval Clin Pract. 2021. PMID: 32529738
Helmet versus non-helmet treatment in infants with positional cranial deformation: A systematic review and meta-analysis.
de Sousa YG, Marques Lopes TL, Soares ÁM, Cavalcante MA, Rangel JF, de Macedo Filho L, Balsells MD, Gervásio DA, de Melo Pereira IF, Duarte de Queiroz AG, de Almeida MV, Amorim Neto GP, Urbano Cavalcante CG, Freitas de Albuquerque LA. de Sousa YG, et al. Among authors: rangel jf. J Clin Neurosci. 2025 Sep;139:111431. doi: 10.1016/j.jocn.2025.111431. Epub 2025 Jun 26. J Clin Neurosci. 2025. PMID: 40578012
Vitamin B12.
SPIES TD, LOPEZ GG, STONE RE, LOPEZ-TOCA R, REBOREDO A, RANGEL JG. SPIES TD, et al. Among authors: rangel jg. Int Z Vitaminforsch Beih. 1952;23(3):440-5. Int Z Vitaminforsch Beih. 1952. PMID: 14937889 No abstract available.
Folic acid.
SPIES TD, LOPEZ GG, STONE RE, LOPEZ-TOCA R, REBOREDO A, RANGEL JG. SPIES TD, et al. Among authors: rangel jg. Int Z Vitaminforsch Beih. 1952;23(3):445-51. Int Z Vitaminforsch Beih. 1952. PMID: 14937890 No abstract available.
165 results